Work

Centaurus (JNJ5467414SMM2001): A Randomized Phase II Trial to Evaluate Three Daratumumab (DARA) Dose Schedules in Smoldering Multiple Myeloma (SMM)

Year: 2015

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2015.07.398

Authors: C.C. Hofmeister, H. Goldschmidt, M. Qi, R. Bandekar, H. Amin, T. Ahmadi, O. Landgren

Institutions: The Ohio State University, University Hospital Heidelberg, National Center for Tumor Diseases, Janssen Research & Development (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2292438979

FWCI: 0.26

Cites:

Cited by: 1

Related to: 10